Live Breaking News & Updates on Vesical Imaging

Andrea Necchi, MD, discusses the efficacy and safety data reported from the FIDES-02 study, explains the clinical relevance of these data despite the trial’s negative result, and highlights several other influential studies presented at the 2023 Genitourinary Cancers Symposium. ....

Giorgio Brembilla , Andrea Necchi , Astellas Pharma , Glaxosmithkline Incyte , Salute San Raffaele University , Bristol Myers Squibb , Gilead Sciences , Foundation Medicine , Scientific Institute , Cancers Symposium , Genitourinary Medical Oncology , Raffaele Hospital , Vita Salute San Raffaele University , Vesical Imaging , Data System , Ospedale San Raffaele , Basilea Pharmaceutical , Clovis Oncology , Merck Sharp , Rainier Therapeutics , Derazantinib Monotherapy , Metastatic Urothelial Cancer , Fides 01 Study , Patients With Locally Advanced Or Metastatic Intrahepatic Cholangiocarcinoma Expressing Fgfr2 Alterations , Fides 02 Study , Irccs San Raffaele Hospital And Scientific Institute ,